Malaria vaccine (FMP012) - Walter Reed Army Institute of Research/US Army Medical Research and Materiel Command

Drug Profile

Malaria vaccine (FMP012) - Walter Reed Army Institute of Research/US Army Medical Research and Materiel Command

Alternative Names: Falciparum malaria protein-12 vaccine; FMP012; FMP012 subunit malaria vaccine - WRAIR; FMP012/AS01B malaria vaccine; Malaria vaccine PfCelTOS WRAIR; Malaria vaccine recombinant FMP012; Plasmodium falciparum FMP012 vaccine; Plasmodium falciparum PfCelTOS vaccine; Plasmodium falciparum vaccine FMP012; Recombinant FMP012 malaria vaccine

Latest Information Update: 15 Sep 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator United States Army Medical Research and Materiel Command; Walter Reed Army Institute of Research
  • Class Antimalarials; Parasitic vaccines; Subunit vaccines; Synthetic vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Preclinical Malaria

Most Recent Events

  • 11 Jun 2014 Preclinical trials in Malaria (Prevention) in USA (IM)
  • 11 Jun 2014 Walter Reed Army Institute of Research and US Army Medical Research and Materiel Command plan a phase I trial for Malaria (Prevention) in USA (NCT02174978)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top